Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
22 hedge funds and large institutions have $897K invested in Aptose Biosciences, Inc. in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
4% less funds holding
Funds holding: 23 → 22 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
32% less capital invested
Capital invested by funds: $1.33M → $897K (-$431K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
+$759K |
| 2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$91.6K |
| 3 |
HF
HRT Financial
New York
|
+$13.1K |
| 4 |
NFG
Nations Financial Group
Cedar Rapids,
Iowa
|
+$5.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$776K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$31.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 4 |
Morgan Stanley
New York
|
-$7.86K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$5.78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCBWMS
26
Texas Capital Bank Wealth Management Services
Dallas,
Texas
| – | -$5.12K | -415 | Closed |
|
|
PP
27
PDS Planning
Dublin,
Ohio
| – | -$4.11K | -333 | Closed |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$328 | -36 | -62% |
|
29
Wells Fargo
San Francisco,
California
| – | -$18 | -2 | Closed |
|
APTO Hedge Fund Activity: Q4 2024 in Review
22 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q4 2024, worth a combined $897K — down 32% from $1.33M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of APTO and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Bleichroeder LP, opening a new position worth an estimated $759K. The largest seller was Armistice Capital, exiting entirely with an estimated $776K sold.
- 22 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q4 2024, down from 23 in Q3 2024.
- Funds reported $897K of Aptose Biosciences, Inc. stock for Q4 2024, down 32% quarter-over-quarter.
- 4 funds opened new Aptose Biosciences, Inc. positions in Q4 2024 and 5 closed out, a net change of -1 holder.
- The largest Aptose Biosciences, Inc. buyer in Q4 2024 was Bleichroeder LP, an estimated $759K added.
- The largest Aptose Biosciences, Inc. seller in Q4 2024 was Armistice Capital, an estimated $776K sold.
Based on aggregated 13F filings for Q4 2024.